In agreement with the literature and the results mentioned above, the mitogen-activated protein kinase 14 (MAPK14), also called p38-α, was also identified as a significant predicted regulator with a strong tendency toward activation in the HF treatment. The gene discussed is MAP3K14; the disease is hydrops fetalis.